Socioeconomic disparities in breast cancer survival: Relation to stage at diagnosis, treatment and race

BMC Cancer

Volumn 9, Issue , 2009, Pages 364-

  Yu, Xue Q ^a  

^a CANCER RESEARCH DIVISION   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; BREAST CANCER; BREAST SURGERY; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER REGISTRY; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; DEMOGRAPHY; FEMALE; HAZARD RATIO; HUMAN; MAJOR CLINICAL STUDY; RACE DIFFERENCE; RISK ASSESSMENT; RURAL AREA; SOCIAL STATUS; SURVIVAL TIME; URBAN AREA;

EID: 70450237110     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-9-364     Document Type: Article

References (40)

1. Bradley CJ, Given CW, Roberts C. Race, socioeconomic status, and breast cancer treatment and survival. J Natl Cancer Inst 2002, 94(7):490-496.
2. Kim SH, Ferrante J, Won BR, Hameed M. Barriers to adequate follow-up during adjuvant therapy may be important factors in the worse outcome for Black women after breast cancer treatment. World J Surg Oncol 2008, 6:26. 10.1186/1477-7819-6-26, 2277417, 18298840.
3. Byers TE, Wolf HJ, Bauer KR, Bolick-Aldrich S, Chen VW, Finch JL, Fulton JP, Schymura MJ, Shen T, Van Heest S. The impact of socioeconomic status on survival after cancer in the United States: findings from the National Program of Cancer Registries Patterns of Care Study. Cancer 2008, 113(3):582-591. 10.1002/cncr.23567, 18613122.
4. Du XL, Fang S, Meyer TE. Impact of treatment and socioeconomic status on racial disparities in survival among older women with breast cancer. Am J Clin Oncol 2008, 31(2):125-132. 10.1097/COC.0b013e3181587890, 18391595.
5. Newman LA, Griffith KA, Jatoi I, Simon MS, Crowe JP, Colditz GA. Meta-analysis of survival in African American and white American patients with breast cancer: ethnicity compared with socioeconomic status. J Clin Oncol 2006, 24(9):1342-1349. 10.1200/JCO.2005.03.3472, 16549828.
6. Ward E, Jemal A, Cokkinides V, Singh GK, Cardinez C, Ghafoor A, Thun M. Cancer disparities by race/ethnicity and socioeconomic status. CA Cancer J Clin 2004, 54(2):78-93. 10.3322/canjclin.54.2.78, 15061598.
7. Yu XQ, O'Connell DL, Gibberd RW, Armstrong BK. Assessing the impact of socio-economic status on cancer survival in New South Wales, Australia 1996-2001. Cancer Causes Control 2008, 19(10):1383-1390. 10.1007/s10552-008-9210-1, 18704715.
8. MacKinnon JA, Duncan RC, Huang Y, Lee DJ, Fleming LE, Voti L, Rudolph M, Wilkinson JD. Detecting an association between socioeconomic status and late stage breast cancer using spatial analysis and area-based measures. Cancer Epidemiol Biomarkers Prev 2007, 16(4):756-762. 10.1158/1055-9965.EPI-06-0392, 17416767.
9. Sabatino SA, Coates RJ, Uhler RJ, Breen N, Tangka F, Shaw KM. Disparities in mammography use among US women aged 40-64 years, by race, ethnicity, income, and health insurance status, 1993 and 2005. Med Care 2008, 46(7):692-700. 10.1097/MLR.0b013e31817893b1, 18580388.
10. Ward E, Halpern M, Schrag N, Cokkinides V, DeSantis C, Bandi P, Siegel R, Stewart A, Jemal A. Association of insurance with cancer care utilization and outcomes. CA Cancer J Clin 2008, 58(1):9-31. 10.3322/CA.2007.0011, 18096863.
11. Bickell NA, LePar F, Wang JJ, Leventhal H. Lost opportunities: physicians' reasons and disparities in breast cancer treatment. J Clin Oncol 2007, 25(18):2516-2521. 10.1200/JCO.2006.09.5539, 17577028.
12. Edwards BK, Brown ML, Wingo PA, Howe HL, Ward E, Ries LA, Schrag D, Jamison PM, Jemal A, Wu XC. Annual report to the nation on the status of cancer, 1975-2002 featuring population-based trends in cancer treatment. J Natl Cancer Inst 2005, 97(19):1407-1427.
13. Curtis E, Quale C, Haggstrom D, Smith-Bindman R. Racial and ethnic differences in breast cancer survival: how much is explained by screening, tumor severity, biology, treatment, comorbidities, and demographics?. Cancer 2008, 112(1):171-180. 10.1002/cncr.23131, 2674622, 18040998.
14. Bickell NA, Cohen A. Understanding reasons for underuse: an approach to improve quality and reduce disparities in breast cancer treatment. Mt Sinai J Med 2008, 75(1):23-30. 10.1002/msj.20013, 18306239.
15. Bilimoria KY, Bentrem DJ, Feinglass JM, Stewart AK, Winchester DP, Talamonti MS, Ko CY. Directing surgical quality improvement initiatives: comparison of perioperative mortality and long-term survival for cancer surgery. J Clin Oncol 2008, 26(28):4626-4633. 10.1200/JCO.2007.15.6356, 18574159.
16. Esnaola NF, Knott K, Finney C, Gebregziabher M, Ford ME. Urban/rural residence moderates effect of race on receipt of surgery in patients with nonmetastatic breast cancer: a report from the South Carolina central cancer registry. Ann Surg Oncol 2008, 15(7):1828-1836. 10.1245/s10434-008-9898-x, 18398659.
17. Hershman DL, Wang X, McBride R, Jacobson JS, Grann VR, Neugut AI. Delay of adjuvant chemotherapy initiation following breast cancer surgery among elderly women. Breast Cancer Res Treat 2006, 99(3):313-321. 10.1007/s10549-006-9206-z, 16583264.
18. Gross CP, Smith BD, Wolf E, Andersen M. Racial disparities in cancer therapy: did the gap narrow between 1992 and 2002?. Cancer 2008, 112(4):900-908. 10.1002/cncr.23228, 18181101.
19. Haas JS, Earle CC, Orav JE, Brawarsky P, Keohane M, Neville BA, Williams DR. Racial segregation and disparities in breast cancer care and mortality. Cancer 2008, 113(8):2166-2172. 10.1002/cncr.23828, 2575036, 18798230.
20. Fritz A, Percy C, Jack A, Shanmugaratnam K, Sobin L, Parkin D, Whelan S, . eds International Classification of Diseases for Oncology. 2000, Geneva, Switzerland: World Health Organisation, 3.
21. Singh GK, Miller B, Hankey B, Edwards BK. Area socioeconomic variation in U.S. cancer incidence, mortality, stage, treatment, and survival, 1975-1999. 2003, Bethesda: MD: National Cancer Institute.
22. Greene F, Page D, Fleming I, Fritz A, Balch C, Haller D, Morrow M, . eds AJCC Cancer Staging Manual. 2002, Philadelphia: Springer, 6.
23. Truong PT, Vinh-Hung V, Cserni G, Woodward WA, Tai P, Vlastos G. The number of positive nodes and the ratio of positive to excised nodes are significant predictors of survival in women with micrometastatic node-positive breast cancer. Eur J Cancer 2008, 44(12):1670-1677. 10.1016/j.ejca.2008.05.011, 18595686.
24. Yu XQ, O'Connell DL, Gibberd RW, Smith DP, Dickman PW, Armstrong BK. Estimating regional variation in cancer survival: a tool for improving cancer care. Cancer Causes Control 2004, 15(6):611-618. 10.1023/B:CACO.0000036165.13089.e8, 15280640.
25. Bradburn MJ, Clark TG, Love SB, Altman DG. Survival analysis Part III: multivariate data analysis -- choosing a model and assessing its adequacy and fit. Br J Cancer 2003, 89(4):605-611. 10.1038/sj.bjc.6601120, 2376927, 12915864.
26. UCLA: Academic Technology Services, Statistical Consulting Group. , http://www.ats.ucla.edu/stat/sas/seminars/sas_survival/
27. Woods LM, Rachet B, Coleman MP. Origins of socio-economic inequalities in cancer survival: a review. Ann Oncol 2006, 17(1):5-19. 10.1093/annonc/mdj007, 16143594.
28. Krieger N, Chen JT, Waterman PD, Soobader MJ, Subramanian SV, Carson R. Geocoding and monitoring of US socioeconomic inequalities in mortality and cancer incidence: does the choice of area-based measure and geographic level matter?: the Public Health Disparities Geocoding Project. Am J Epidemiol 2002, 156(5):471-482. 10.1093/aje/kwf068, 12196317.
29. Robinson JM, Shavers V. The role of health insurance coverage in cancer screening utilization. J Health Care Poor Underserved 2008, 19(3):842-856. 10.1353/hpu.0.0048, 18677074.
30. Schootman M, Walker MS, Jeffe DB, Rohrer JE, Baker EA. Breast cancer screening and incidence in communities with a high proportion of uninsured. Am J Prev Med 2007, 33(5):379-386. 10.1016/j.amepre.2007.07.032, 2100034, 17950403.
31. Yabroff KR, Breen N, Vernon SW, Meissner HI, Freedman AN, Ballard-Barbash R. What factors are associated with diagnostic follow-up after abnormal mammograms? Findings from a U.S. National Survey. Cancer Epidemiol Biomarkers Prev 2004, 13(5):723-732.
32. Hershman DL, Wang X, McBride R, Jacobson JS, Grann VR, Neugut AI. Delay in initiating adjuvant radiotherapy following breast conservation surgery and its impact on survival. Int J Radiat Oncol Biol Phys 2006, 65(5):1353-1360.
33. Bickell NA, Wang JJ, Oluwole S, Schrag D, Godfrey H, Hiotis K, Mendez J, Guth AA. Missed opportunities: racial disparities in adjuvant breast cancer treatment. J Clin Oncol 2006, 24(9):1357-1362. 10.1200/JCO.2005.04.5799, 16549830.
34. Hershman DL, Buono D, McBride RB, Tsai WY, Joseph KA, Grann VR, Jacobson JS. Surgeon characteristics and receipt of adjuvant radiotherapy in women with breast cancer. J Natl Cancer Inst 2008, 100(3):199-206. 10.1093/jnci/djm320, 18230795.
35. Bach PB, Pham HH, Schrag D, Tate RC, Hargraves JL. Primary care physicians who treat blacks and whites. N Engl J Med 2004, 351(6):575-584. 10.1056/NEJMsa040609, 15295050.
36. Baquet CR, Mishra SI, Commiskey P, Ellison GL, DeShields M. Breast cancer epidemiology in blacks and whites: disparities in incidence, mortality, survival rates and histology. J Natl Med Assoc 2008, 100(5):480-488.
37. Chu KC, Lamar CA, Freeman HP. Racial disparities in breast carcinoma survival rates: seperating factors that affect diagnosis from factors that affect treatment. Cancer 2003, 97(11):2853-2860. 10.1002/cncr.11411, 12767100.
38. Lucas FL, Stukel TA, Morris AM, Siewers AE, Birkmeyer JD. Race and surgical mortality in the United States. Ann Surg 2006, 243(2):281-286. 10.1097/01.sla.0000197560.92456.32, 1448914, 16432363.
39. Srokowski TP, Fang S, Duan Z, Buchholz TA, Hortobagyi GN, Goodwin JS, Giordano SH. Completion of adjuvant radiation therapy among women with breast cancer. Cancer 2008, 113(1):22-29. 10.1002/cncr.23513, 18442124.
40. Albain KS, Unger JM, Crowley JJ, Coltman CA, Hershman DL. Racial Disparities in Cancer Survival Among Randomized Clinical Trials Patients of the Southwest Oncology Group. J Natl Cancer Inst 2009, 101(14):984-992. 10.1093/jnci/djp175, 19584328.